뇌염 치료 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측, 유형별, 치료별, 증상별, 최종사용자별, 지역별 부문, 경쟁(2020-2030년)
Encephalitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Treatment, By Symptoms, by End-User, By Region & Competition, 2020-2030F
상품코드:1691732
리서치사:TechSci Research
발행일:2025년 03월
페이지 정보:영문 182 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
뇌염 치료제 세계 시장 규모는 2024년 186억 달러로 평가되었으며, 2030년까지 4.80%의 연평균 복합 성장률(CAGR)을 나타내며 예측 기간 동안 괄목할 만한 성장이 예상됩니다.
뇌염은 뇌의 염증을 특징으로 하는 병입니다. 바이러스 감염, 자가면역 반응, 세균 감염, 원인 불명 등 다양한 요인에 의해 발생합니다. 뇌염은 경증부터 중증까지 다양하며, 그 증상은 근본적인 원인과 뇌의 염증 정도에 따라 크게 달라집니다. 뇌염은 바이러스(바이러스성 뇌염), 자가면역반응(자가면역성 뇌염), 세균(세균성 뇌염), 기생충, 그리고 원인불명의 유발 요인 등 여러 가지 요인에 의해 발생합니다. 바이러스는 뇌염의 가장 흔한 원인입니다. 이것은 가장 흔한 형태의 뇌염입니다. 바이러스성 뇌염을 일으키는 바이러스에는 단순 헤르페스 바이러스(HSV), 수두 대상포진 바이러스(VZV), 엔테로바이러스, 아르보바이러스(예: 웨스트 나일 바이러스) 등이 있습니다. 뇌염의 증상은 다양하지만 발열, 두통, 정신상태의 변화(착란, 방향감각 상실 등), 경련, 근력저하, 언어장애, 협응운동장애 등이 흔하게 나타납니다. 뇌염이 심해지면 혼수상태에 빠지기도 합니다. 예를 들어, WHO에 따르면 일본뇌염 바이러스(JEV)는 뎅기열, 황열병, 웨스트 나일 바이러스와 관련된 플라비 바이러스로 주로 모기, 특히 Culex tritaeniorhynchus에 의해 매개되며, JEV는 아시아 국가에서 바이러스성 뇌염의 주요 원인으로 연간 약 10만 건의 임상사례가 보고되고 있습니다. 연간 약 10만 건의 임상사례가 보고되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
186억 달러
시장 규모 : 2030년
244억 4,000만 달러
CAGR : 2025-2030년
4.80%
급성장 부문
항바이러스제
최대 시장
북미
시장 성장 촉진요인
진단의 발전
주요 시장 이슈
새로운 병원체
주요 시장 동향
신경 재활 및 지지 요법
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 뇌염 치료 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
유형별(원발성 뇌염, 2차성 뇌염)
치료별(항바이러스제, 스테로이드 주사, 항생제, 면역글로불린 요법, 혈장 교환 요법, 기타)
증상별(발열, 졸음, 두통, 인격 변화, 역자극성, 혼란, 탈진감, 발작, 기타)
최종사용자별(클리닉, 병원, 기타)
지역별
기업별(2024년)
시장 맵
제6장 아시아태평양의 뇌염 치료 시장 전망
시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
인도
호주
일본
한국
제7장 유럽의 뇌염 치료 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
스페인
이탈리아
영국
제8장 북미의 뇌염 치료 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
멕시코
캐나다
제9장 남미의 뇌염 치료 시장 전망
시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 뇌염 치료 시장 전망
시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
제품 출시
인수합병(M&A)
제13장 세계의 뇌염 치료 시장 : SWOT 분석
제14장 Porter의 Five Forces 분석
업계내 경쟁
신규 참여 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 PESTEL 분석
제16장 경쟁 구도
Allergan Inc.
Merck & Co., Inc.
Pfizer Inc.
GlaxoSmithKline plc
Sun Pharmaceutical Industries Ltd.
Basilea Pharmaceutica Ltd.
Abbott Ltd.
F. Hoffmann-La Roche Ltd.
Novartis AG
Bayer AG
제17장 전략적 제안
제18장 리서치사에 대해 & 면책사항
LSH
영문 목차
영문목차
Global Encephalitis Treatment Market was valued at USD 18.60 billion in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 4.80% through 2030. Encephalitis is a medical condition characterized by inflammation of the brain. It can be caused by various factors, including viral infections, autoimmune reactions, bacterial infections, and, in some cases, unknown causes. Encephalitis can range from mild to severe, and its symptoms can vary widely depending on the underlying cause and the extent of brain inflammation. Encephalitis can be caused by several factors, including viruses (viral encephalitis), autoimmune reactions (autoimmune encephalitis), bacteria (bacterial encephalitis), parasites, and, in some cases, unknown triggers. Viruses are the most common cause of encephalitis. This is the most common form of encephalitis. Viruses that can cause viral encephalitis include herpes simplex virus (HSV), varicella-zoster virus (VZV), enteroviruses, arboviruses (e.g., West Nile virus), and others. The symptoms of encephalitis can vary but often include fever, headache, altered mental status (such as confusion or disorientation), seizures, muscle weakness, and speech or coordination problems. In severe cases, encephalitis can lead to coma. For instance, according to WHO, the Japanese encephalitis virus (JEV) is a flavivirus related to dengue, yellow fever, and West Nile viruses, primarily transmitted by mosquitoes, especially Culex tritaeniorhynchus. JEV is the leading cause of viral encephalitis in several Asian countries, with approximately 100,000 clinical cases reported annually.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 18.60 Billion
Market Size 2030
USD 24.44 Billion
CAGR 2025-2030
4.80%
Fastest Growing Segment
Antiviral Agents
Largest Market
North America
Key Market Drivers
Advancements in Diagnostics
Polymerase chain reaction (PCR) and other molecular techniques have revolutionized the diagnosis of encephalitis, particularly for viral forms. These methods allow for the detection of viral genetic material (DNA or RNA) in cerebrospinal fluid (CSF) or other clinical samples, providing rapid and specific identification of the causative virus. Next-Generation Sequencing (NGS) technologies have enabled comprehensive genomic analysis of pathogens, including viruses, in encephalitis cases. This can help identify rare or emerging pathogens and enhance our understanding of the genetic diversity of viral strains. Serological tests, including enzyme-linked immunosorbent assays (ELISAs), are used to detect specific antibodies in the blood or CSF. These tests can confirm exposure to certain viruses and aid in diagnosis. Advanced neuroimaging techniques, such as magnetic resonance imaging (MRI) and computed tomography (CT) scans, allow for the visualization of brain structures and abnormalities. Neuroimaging can help identify signs of inflammation, lesions, or structural changes associated with encephalitis.
Key Market Challenges
Emerging Pathogens
When a new or emerging pathogen is responsible for encephalitis cases, there may be a lack of specific antiviral or treatment options. Healthcare providers may need to rely on broad-spectrum antivirals until more targeted treatments are developed. Identifying and diagnosing emerging pathogens can be challenging. Existing diagnostic tests may not be effective in detecting these novel pathogens, leading to delays in diagnosis and treatment. Research and development efforts are required to understand the biology of the emerging pathogen and develop effective treatments. This process can be time-consuming and may not provide immediate solutions for patients. Addressing emerging pathogens often requires collaboration among researchers, healthcare organizations, and governments on a global scale. Coordinated efforts are necessary to share data, conduct research, and develop treatments. Healthcare systems and public health agencies need to be prepared to respond to outbreaks of encephalitis caused by emerging pathogens. This includes having strategies for rapid diagnosis, isolation, and treatment of affected individuals. In some cases, emerging pathogens may necessitate the development of vaccines to prevent encephalitis. The process of vaccine development can take time, and there may be challenges in ensuring widespread vaccine coverage. Enhanced surveillance and monitoring systems are crucial for detecting the emergence of new pathogens and tracking their spread. Early detection can lead to faster responses and containment. Emerging pathogens can develop drug resistance over time, making previously effective treatments less effective.
Key Market Trends
Neurorehabilitation and Supportive Care
Healthcare providers are increasingly offering comprehensive care programs that include neurorehabilitation services, along with medical treatment, to address the physical, cognitive, and emotional challenges faced by encephalitis patients. The involvement of rehabilitation specialists, including physical therapists, occupational therapists, and speech-language pathologists, is becoming standard in the care of encephalitis patients. These specialists work to improve mobility, functional independence, and communication skills. Cognitive deficits are common in encephalitis survivors. Cognitive rehabilitation programs focus on improving memory, attention, problem-solving, and other cognitive functions to enhance the patient's overall quality of life. Neurorehabilitation aims to maximize the patient's functional independence, helping them regain lost abilities or develop compensatory strategies to cope with impairments. Treatment plans are increasingly tailored to the specific needs of each patient. Individualized care accounts for the unique challenges and goals of the individual. In some cases, neurorehabilitation can be provided in a home-based setting, making it more accessible and convenient for patients, particularly those with limited mobility. Supportive care services encompass a wide range of offerings, including psychological support, counseling, and assistance with activities of daily living. These services help patients and their families navigate the emotional and practical aspects of living with encephalitis-related disabilities. Recognizing the critical role of caregivers, support services are also extended to caregivers, providing them with the resources, education, and respite they need to care for their loved ones effectively.
Key Market Players
Allergan Inc.
Merck & Co., Inc.
Pfizer Inc.
GlaxoSmithKline plc
Basilea Pharmaceutica Ltd.
Abbott Laboratories Ltd.
F. Hoffmann-La Roche Ltd.
Novartis AG
Bayer AG
Sun Pharmaceutical Industries Ltd.,
Report Scope:
In this report, the Global Encephalitis Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Encephalitis Treatment Market, By Type:
Primary Encephalitis
Secondary Encephalitis
Encephalitis Treatment Market, By Treatment:
Antiviral Agents
Steroid Injection
Antibiotics
Immunoglobulin Therapy
Plasmapheresis
Others
Encephalitis Treatment Market, By Symptoms:
Fever
Drowsiness
Headaches
Personality Changes
Irritability
Confusion
Weakness
Seizures
Others
Encephalitis Treatment Market, By End-User:
Clinic
Hospital
Others
Encephalitis Treatment Market, By region:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
South Korea
Australia
Japan
Europe
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Encephalitis Treatment Market.
Available Customizations:
Global Encephalitis Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Encephalitis Treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Primary Encephalitis, Secondary Encephalitis)
